Post-earnings recap
Reported
Mon, May 2, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp reported a slight earnings beat, but the stock fell by 1.9% in response. Investors may be concerned about the lack of revenue data and the absence of future guidance. The overall market sentiment appears cautious as management addresses ongoing challenges.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.85 | N/A | +1.92% |
Management acknowledged the current market conditions but expressed a commitment to improving operational performance. There was no specific guidance provided for future quarters.
Management highlighted ongoing challenges in the market.
They noted a focus on operational efficiency moving forward.